• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者左心室舒张功能障碍风险评估列线图的开发

Development of a Nomogram for Estimating the Risk of Left Ventricular Diastolic Dysfunction in Patients with Non-Alcoholic Fatty Liver Disease.

作者信息

Xia Jinying, Li Jianhui, Jin Guang, Yao Danzhen, Hua Qifeng

机构信息

Department of Endocrinology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China.

Department of Ultrasound, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2022 Jun 9;15:1749-1759. doi: 10.2147/DMSO.S371208. eCollection 2022.

DOI:10.2147/DMSO.S371208
PMID:35706476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9191691/
Abstract

BACKGROUND

Patients with non-alcoholic fatty liver disease (NAFLD) are more likely to develop left ventricular diastolic dysfunction (LVDD). Although lifestyle adjustments contribute to the improvement of NAFLD, thereby delaying or even preventing LVDD progression, it is difficult to maintain a healthy lifestyle, resulting in a higher incidence of LVDD in NAFLD patients.

OBJECTIVE

This study aims to develop a nomogram for assessing the risk of LVDD progression in NAFLD patients to increase their adherence to therapeutic interventions and adjust their treatment regimens timely.

METHODS

A total of 148 medical records of NAFLD patients were retrospectively analyzed. Sixty-three were assigned to the LVDD+ group and 85 were assigned to the LVDD- group. The independent correlates of LVDD, which were screened via least absolute shrinkage and selection operator logistic regression model first, followed by multivariate Logistic regression model, constituted the nomogram to determine the likelihood of LVDD in NAFLD patients.

RESULTS

Number of comorbidities, glycosylated hemoglobin, and epicardial adipose tissue (EAT) volume index were independent correlates of LVDD (all < 0.05). They served as components in the newly developed nomogram. It obtained significant clinical benefit in detecting NAFLD patients at the risk of LVDD progression, with satisfied discrimination and calibration.

CONCLUSION

We developed a nomogram for identifying NAFLD patients with a normal diastolic function who are at risk of LVDD progression, thus contributing to effective prevention of LVDD progression.

摘要

背景

非酒精性脂肪性肝病(NAFLD)患者更易发生左心室舒张功能障碍(LVDD)。尽管生活方式调整有助于改善NAFLD,从而延缓甚至预防LVDD进展,但保持健康的生活方式很困难,导致NAFLD患者中LVDD的发病率较高。

目的

本研究旨在开发一种列线图,用于评估NAFLD患者LVDD进展的风险,以提高他们对治疗干预的依从性,并及时调整治疗方案。

方法

回顾性分析了148例NAFLD患者的病历。63例被分配到LVDD+组,85例被分配到LVDD-组。首先通过最小绝对收缩和选择算子逻辑回归模型,然后通过多变量逻辑回归模型筛选出LVDD的独立相关因素,构成列线图以确定NAFLD患者发生LVDD的可能性。

结果

合并症数量、糖化血红蛋白和心外膜脂肪组织(EAT)体积指数是LVDD的独立相关因素(均P<0.05)。它们作为新开发列线图的组成部分。该列线图在检测有LVDD进展风险的NAFLD患者方面具有显著的临床益处,具有满意的区分度和校准度。

结论

我们开发了一种列线图,用于识别舒张功能正常但有LVDD进展风险的NAFLD患者,从而有助于有效预防LVDD进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/9f954c21475c/DMSO-15-1749-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/f1b5e8cd2d98/DMSO-15-1749-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/36ba91a9103f/DMSO-15-1749-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/f7fe2f1b57da/DMSO-15-1749-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/da0ed0754981/DMSO-15-1749-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/76cf3ad22e98/DMSO-15-1749-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/0179adb8ba64/DMSO-15-1749-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/9f954c21475c/DMSO-15-1749-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/f1b5e8cd2d98/DMSO-15-1749-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/36ba91a9103f/DMSO-15-1749-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/f7fe2f1b57da/DMSO-15-1749-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/da0ed0754981/DMSO-15-1749-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/76cf3ad22e98/DMSO-15-1749-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/0179adb8ba64/DMSO-15-1749-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/9191691/9f954c21475c/DMSO-15-1749-g0007.jpg

相似文献

1
Development of a Nomogram for Estimating the Risk of Left Ventricular Diastolic Dysfunction in Patients with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者左心室舒张功能障碍风险评估列线图的开发
Diabetes Metab Syndr Obes. 2022 Jun 9;15:1749-1759. doi: 10.2147/DMSO.S371208. eCollection 2022.
2
Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study.2 型糖尿病合并非酒精性脂肪性肝病患者纤维化进展风险的定量评估列线图:一项初步研究。
Front Endocrinol (Lausanne). 2022 Jun 28;13:917304. doi: 10.3389/fendo.2022.917304. eCollection 2022.
3
Left ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis.肝移植中的左心室舒张功能障碍:与非酒精性脂肪性肝炎的关联更强。
Clin Exp Hepatol. 2020 Jun;6(2):158-162. doi: 10.5114/ceh.2020.95893. Epub 2020 Jun 1.
4
Development of a nomogram for predicting the risk of left ventricular diastolic function in subjects with type-2 diabetes mellitus.建立预测 2 型糖尿病患者左心室舒张功能障碍风险的列线图。
Int J Cardiovasc Imaging. 2022 Jan;38(1):15-23. doi: 10.1007/s10554-021-02338-5. Epub 2021 Nov 16.
5
Impact of epicardial adipose tissue on diastolic dysfunction in patients with chronic coronary syndrome and preserved left ventricular ejection fraction.心外膜脂肪组织对慢性冠状动脉综合征且左心室射血分数保留患者舒张功能障碍的影响。
Eur Heart J Imaging Methods Pract. 2024 Jun 5;2(1):qyae056. doi: 10.1093/ehjimp/qyae056. eCollection 2024 Jan.
6
Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis.非酒精性脂肪性肝病是否是 2 型糖尿病患者左心室舒张功能障碍的标志?系统评价和荟萃分析。
BMJ Open Diabetes Res Care. 2023 Feb;11(1). doi: 10.1136/bmjdrc-2022-003198.
7
Non-alcoholic Fatty Liver Disease and Its Association With Left Ventricular Diastolic Dysfunction: A Systematic Review.非酒精性脂肪性肝病及其与左心室舒张功能障碍的关联:一项系统综述。
Cureus. 2023 Aug 6;15(8):e43013. doi: 10.7759/cureus.43013. eCollection 2023 Aug.
8
Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.开发和应用一种新模型预测血脂正常的消瘦型糖尿病前期人群中非酒精性脂肪肝疾病的风险。
Lipids Health Dis. 2022 Dec 31;21(1):149. doi: 10.1186/s12944-022-01752-5.
9
Association of Glycosylated Haemoglobin (HbA1c) Level With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes.2型糖尿病患者糖化血红蛋白(HbA1c)水平与左心室舒张功能障碍的关联
Cureus. 2022 Nov 17;14(11):e31626. doi: 10.7759/cureus.31626. eCollection 2022 Nov.
10
Association of Local Epicardial Adipose Tissue Depots and Left Ventricular Diastolic Performance in Patients With Preserved Left Ventricular Ejection Fraction.局部心外膜脂肪组织蓄积与左心室射血分数保留患者左心室舒张功能的相关性。
Circ J. 2020 Jan 24;84(2):203-216. doi: 10.1253/circj.CJ-19-0793. Epub 2020 Jan 17.

引用本文的文献

1
Age-Related Characteristics of Diastolic Dysfunction in Type 2 Diabetes Patients.2型糖尿病患者舒张功能障碍的年龄相关特征
J Clin Med. 2025 Aug 15;14(16):5772. doi: 10.3390/jcm14165772.

本文引用的文献

1
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.非酒精性脂肪性肝病(NAFLD):病理生理学、临床管理和减肥效果的综述。
BMC Endocr Disord. 2022 Mar 14;22(1):63. doi: 10.1186/s12902-022-00980-1.
2
[Update on diastolic heart failure].[舒张性心力衰竭的最新进展]
Inn Med (Heidelb). 2022 Jul;63(7):798-804. doi: 10.1007/s00108-022-01286-z. Epub 2022 Mar 14.
3
Diastolic Cardiac Function by MRI-Imaging Capabilities and Clinical Applications.MRI 成像功能与临床应用评估舒张性心脏功能
Tomography. 2021 Dec 8;7(4):893-914. doi: 10.3390/tomography7040075.
4
Reversible left ventricular diastolic dysfunction-Overview and clinical implications.可逆性左心室舒张功能障碍——概述及临床意义。
Echocardiography. 2020 Nov;37(11):1957-1966. doi: 10.1111/echo.14838. Epub 2020 Sep 1.
5
Left Ventricular Diastolic Dysfunction in Type 2 Diabetes-Progress and Perspectives.2型糖尿病中的左心室舒张功能障碍——进展与展望
Diagnostics (Basel). 2019 Sep 17;9(3):121. doi: 10.3390/diagnostics9030121.
6
Heart Failure in Type 2 Diabetes Mellitus.2 型糖尿病中的心力衰竭。
Circ Res. 2019 Jan 4;124(1):121-141. doi: 10.1161/CIRCRESAHA.118.311371.
7
Epicardial adipose tissue and cardiovascular diseases.心外膜脂肪组织与心血管疾病。
Int J Cardiol. 2019 Mar 1;278:254-260. doi: 10.1016/j.ijcard.2018.09.089. Epub 2018 Oct 1.
8
Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population.心外膜脂肪组织体积与普通人群的非酒精性脂肪性肝病及心血管危险因素相关。
Ther Clin Risk Manag. 2018 Aug 23;14:1499-1506. doi: 10.2147/TCRM.S168345. eCollection 2018.
9
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.糖尿病患者心血管疾病的一级预防
J Am Coll Cardiol. 2017 Aug 15;70(7):883-893. doi: 10.1016/j.jacc.2017.07.001.
10
Diastolic Dysfunction and Hypertension.舒张功能障碍与高血压。
Med Clin North Am. 2017 Jan;101(1):7-17. doi: 10.1016/j.mcna.2016.08.013.